NCT06459453 Effects of Kaltenborn Versus Mulligan Techniques in Rheumatoid Arthritis.
| NCT ID | NCT06459453 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Rheumatoid Arthritis |
| Study Type | INTERVENTIONAL |
| Enrollment | 34 participants |
| Start Date | 2023-11-23 |
| Primary Completion | 2024-07-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 34 participants in total. It began in 2023-11-23 with a primary completion date of 2024-07-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project was a randomized control trial conducted to check the effects of kaltenborn versus mulligan techniques on pain ,range of motion and functional disability in patients with rheumatoid arthritis of the wrist The inflammatory polyarthritis that primarily affects the tiny joints is a hallmark of rheumatoid arthritis, a chronic autoimmune illness. It is characterized by synovial joint degeneration, joint swelling, and joint discomfort, which can result in disability and early death .All patients of chronic stage,convenience sampling technique was used,subjects following eligibility criteria from Shaikh zayed hospital lahore ,were randomly allocated into two groups ,baseline assessment was done.Group A participants were given Kaltenborn mobilization along with conventional physiotherapy.Group B participants were given Mulligan mobilization along with conventional physiotherapy.Post intervention assessment was done via,VAS(visual analogue scale),goniometric measurements of wrist ranges,and QUICK DASH score.3 sessions per week were given,Data was analyzed by using SPSS.
Eligibility Criteria
Inclusion Criteria: * Age group between 18 to 65 years. Patients with less than 15degrees of flexion and 30 degrees of extension. * Male and female both are included. * Patients with chronic RA. * Consider only those patients with Ra factor positive. Patients with less than 10degrees of radial deviation and 15 degrees of ulnar deviation. * Patients willing to participate in the whole treatment session and follow up. Exclusion Criteria: * Patients who had any mental illness (Alzheimer's, Parkinson's disease, Dementia etc) * Patients who had any neurological deficit(paresthesia ,sensory loss, radiculopathy ,myleopathy) * Peripheral vascular diseases. * Any history of surgery related to upper limb. * Patients having metal implants in the upper limbs. Patients with any other serious pathology .
Contact & Investigator
Hajra Anwer
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06459453 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Rheumatoid Arthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06459453 currently recruiting?
Yes, NCT06459453 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT06459453 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT06459453 clinical trial?
NCT06459453 is sponsored by Riphah International University. The principal investigator is Hajra Anwer at Riphah International University. The trial plans to enroll 34 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.